Skip to main content
Signal8

Burnam Bradley Evan

SEC insider (Form 3/4/5 filer). CIK 0002087366. Chief Executive Officer at Turn Therapeutics Inc. (TTRX). 6 reported Form 4/5 transactions since Sep 2024; latest on May 28, 2026. Located in WESTLAKE VILLAGE, CA.

Companies Burnam Bradley Evan has filed insider reports for

  • Turn Therapeutics Inc. (TTRX): Director, Officer, 10% Owner, Chief Executive Officer
Burnam Bradley Evan profile photo

Burnam Bradley Evan

CIK: 0002087366

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (16.7%)

Compensation grants

Other (G, F, J, C, D, …)5 (83.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Turn Therapeutics Inc. logo
TTRX

Turn Therapeutics Inc.

DirectorOfficer10% Owner

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • Turn Therapeutics Inc. logo
    TTRX

    Turn Therapeutics Inc.

    May 28, 2026
    Gift
    Indirect
    300K shares-
  • Turn Therapeutics Inc. logo
    TTRX

    Turn Therapeutics Inc.

    May 28, 2026
    Gift
    Indirect
    300K shares-
  • Turn Therapeutics Inc. logo
    TTRX

    Turn Therapeutics Inc.

    May 28, 2026
    Gift
    Indirect
    300K shares-
  • Turn Therapeutics Inc. logo
    TTRX

    Turn Therapeutics Inc.

    May 28, 2026
    Gift
    Indirect
    300K shares-
  • Turn Therapeutics Inc. logo
    TTRX

    Turn Therapeutics Inc.

    Apr 2, 2026
    Gift
    Indirect
    300K shares-
  • Turn Therapeutics Inc. logo
    TTRX

    Turn Therapeutics Inc.

    Apr 1, 2026
    Award

    Employee stock option (right to buy)

    Direct
    160K shares-

1-6 of 6